Anodyne

Lys-MDMA
Generated by the Chemistry Development Kit (http://github.com/cdk)
Molecular structure via molpic based on CDK
Physical properties
[]
321.4 g/mol [1]
1.2 [1]
Structural Identifiers
[]
C17H27N3O3 [1]
(2S)-2,6-diamino-N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]-N-methylhexanamide [1]
CC(CC1=CC2=C(C=C1)OCO2)N(C)C(=O)[C@H](CCCCN)N [1]
InChI=1S/C17H27N3O3/c1-12(20(2)17(21)14(19)5-3-4-8-18)9-13-6-7-15-16(10-13)23-11-22-15/h6-7,10,12,14H,3-5,8-9,11,18-19H2,1-2H3/t12?,14-/m0/s1 [1]
InChIKeyMJBFXZNNDCEDME-PYMCNQPYSA-N [1]

N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine

N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine is a codrug, prodrug, entactogen and stimulant substance of the methylenedioxyphenethylamine class.

Chemistry

 []

N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine is a racemic mixture of the

Stereoisomers
(1R,16S)-N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamineGenerated by the Chemistry Development Kit (http://github.com/cdk)
(1S,16S)-N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamineGenerated by the Chemistry Development Kit (http://github.com/cdk)

Pharmacology

N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine acts as a for:

Active metabolites
 []
Lysine Generated by the Chemistry Development Kit (http://github.com/cdk)
3,4-Methylenedioxymethamphetamine Generated by the Chemistry Development Kit (http://github.com/cdk)

Subjective effects []

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 166468301, N-(L-Lysinamidyl)-3,4-methylenedioxymethamphetamine. Accessed July 28, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/166468301